Rolfo, Christian <br/><br/>
Pharmacokinetics and Safety of Olaparib in Patients with Advanced Solid Tumours and Renal Impairment.  [electronic resource] 

 -  Clinical pharmacokinetics  09 2019 
 - 1165-1174 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1179-1926 
<br/><br/><label>Standard No.: </label>10.1007/s40262-019-00754-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Female<br/>Humans<br/>Kidney--physiopathology<br/>Male<br/>Metabolic Clearance Rate--drug effects<br/>Middle Aged<br/>Neoplasms--complications<br/>No-Observed-Adverse-Effect Level<br/>Phthalazines--administration & dosage<br/>Piperazines--administration & dosage<br/>Poly(ADP-ribose) Polymerase Inhibitors--administration & dosage<br/>Renal Insufficiency--etiology<br/>Safety